$-0.02
(Market cap
$30 Mln
Recently Viewed
Clear AllMarket cap
$30 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-5 Mln
ROE
-0.8 %
ROCE
-- %
Industry P/E
22.29
EV/EBITDA
27.3
Debt to Equity
0
Book Value
$--
EPS
$-0.1
Face value
--
Shares outstanding
98,796,089
CFO
$-45.12 Mln
EBITDA
$-54.72 Mln
Net Profit
$-61.32 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
India Globalization Capital (IGC)
| 13.9 | 17.3 | 6.3 | 12.4 | -3.0 | -26.3 | -2.2 |
|
BSE Sensex*
| -6.4 | 6.4 | -3.5 | 0.9 | 10.0 | 10.7 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
India Globalization Capital (IGC)
| -16.7 | 19.8 | -12.5 | -67.3 | -37.2 | 147.6 | 125.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
India Globalization Capital (IGC)
|
0.3 | 29.8 | 1.2 | -5.3 | -673.8 | -79.1 | -- | 4.0 |
| 65.0 | 7,282.3 | 3,015.8 | 1,088.4 | 54.0 | 13.6 | 7 | 0.9 | |
| 113.9 | 4,390.5 | 5,261.2 | 199.7 | 11.4 | 86.3 | 22.7 | 15.6 | |
| 16.5 | 7,278.8 | 59.8 | -136.0 | 7,289.8 | -272.8 | -- | 20.0 | |
| 31.8 | 5,056.2 | 2,087.7 | 251.0 | 16.5 | 27.2 | 20.7 | 5.5 | |
| 182.8 | 5,542.3 | 3,788.9 | 270.9 | 11.1 | 13.6 | 21.8 | 3.2 | |
| 68.6 | 3,593.7 | 5,373.7 | 371.8 | 10.9 | 21.3 | 10.1 | 2.1 | |
| 173.5 | 6,678.2 | 1,874.8 | 278.9 | 21.4 | 22.2 | 24.3 | 4.9 | |
| 20.6 | 4,215.2 | 1,635.2 | 67.9 | 4.8 | 8.9 | 64.5 | 4.9 | |
| 177.1 | 5,465.3 | 2,660.8 | 304.1 | 24.9 | 22.3 | 18.8 | 4.4 |
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead... product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland. Address: 10224 Falls Road, Potomac, MD, United States, 20854 Read more
President, CEO & Director
Mr. Ram Mukunda
President, CEO & Director
Mr. Ram Mukunda
Headquarters
Potomac, MD
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of India Globalization Capital Inc (IGC) is $0.32 (NYSE) as of 20-Apr-2026 16:28 EDT. India Globalization Capital Inc (IGC) has given a return of -3.04% in the last 3 years.
Since, TTM earnings of India Globalization Capital Inc (IGC) is negative, P/E ratio is not available.
The P/B ratio of India Globalization Capital Inc (IGC) is 4.02 times as on 13-Apr-2026, a 73 premium to its peers’ median range of 2.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-3.06
|
3.45
|
|
2024
|
-2.04
|
3.62
|
|
2023
|
-1.57
|
1.21
|
|
2022
|
-2.65
|
1.67
|
|
2021
|
-8.39
|
2.25
|
The 52-week high and low of India Globalization Capital Inc (IGC) are Rs 0.50 and Rs 0.24 as of 21-Apr-2026.
India Globalization Capital Inc (IGC) has a market capitalisation of $ 30 Mln as on 13-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in India Globalization Capital Inc (IGC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.